Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-25-004312
Filing Date
2025-04-15
Accepted
2025-04-15 17:24:04
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tennx_s3.htm S-3 200225
2 OPINION tennx_ex51.htm EX-5.1 8962
3 CONSENT tennx_ex231.htm EX-23.1 1969
4 FILING FEE TABLES tennx_ex107.htm EX-FILING FEES 19739
5 tennx_s3img1.jpg GRAPHIC 4489
6 tennx_s3img2.jpg GRAPHIC 4489
  Complete submission text file 0001654954-25-004312.txt   244851
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286557 | Film No.: 25840633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)